Gene: USP6NL
Official Full Name: USP6 N-terminal likeprovided by HGNC
Gene Summary: Enables GTPase activator activity and small GTPase binding activity. Involved in several processes, including plasma membrane to endosome transport; positive regulation of GTPase activity; and retrograde transport, plasma membrane to Golgi. Located in cytoplasmic vesicle and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32876 | USP6NL Knockout cell line (HeLa) | Human | USP6NL | 1:3~1:6 | Negative | Online Inquiry |
KO32877 | USP6NL Knockout cell line (HCT 116) | Human | USP6NL | 1:2~1:4 | Negative | Online Inquiry |
KO32878 | USP6NL Knockout cell line (HEK293) | Human | USP6NL | 1:3~1:6 | Negative | Online Inquiry |
KO32879 | USP6NL Knockout cell line (A549) | Human | USP6NL | 1:3~1:4 | Negative | Online Inquiry |
USP6NL Gene Knockout Cell Lines are a specialized cellular system designed to facilitate the functional analysis of the USP6NL gene, an important player in various cellular processes, including proliferation and differentiation. By specifically knocking out the USP6NL gene, these cell lines provide researchers with a powerful tool to investigate the gene's biological role and its potential implications in diseases such as cancer and genetic disorders.
The key functions of the USP6NL gene involve its participation in cellular pathways that regulate protein stability and signaling cascades. The knockout cell lines utilize a CRISPR-Cas9 mechanism, ensuring precise gene editing with minimal off-target effects. This results in a comprehensive model for studying the repercussions of USP6NL absence, allowing researchers to dissect the molecular underpinnings in various physiological and pathological contexts.
Scientifically, the USP6NL Gene Knockout Cell Lines are invaluable for both basic research and clinical applications. They enable in-depth exploration of USP6NL’s contributions to tumorigenesis and other disorders, offering potential insights into novel therapeutic targets. Furthermore, these cell lines can be harnessed for drug screening and validation, facilitating the discovery of innovative agents that modulate this pathway.
When compared to alternative products, our USP6NL Gene Knockout Cell Lines stand out due to their high efficiency and specificity achieved through unparalleled customization options tailored to specific research needs. This adaptability, combined with the built-in validation of the knockout, enhances their reliability and utility in translational research.
For researchers and clinicians focused on advancing their understanding of genetic mechanisms, the USP6NL Gene Knockout Cell Lines offer a robust platform that bridges laboratory findings with potential clinical applications. Coupled with our company’s extensive expertise in gene editing technologies and commitment to high-quality biological products, these cell lines represent an essential addition to any research toolkit aimed at unraveling complex biological questions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.